Original paper
Intratympanic infliximab is a safe and effective rescue therapy for refractory immune-mediated hearing loss
Volume: 277, Issue: 2, Pages: 393 - 400
Published: Nov 5, 2019
Abstract
To determine the efficacy and safety of the intratympanic infiltration of infliximab at the hearing threshold of patients in follow-up for refractory immune-mediated hearing loss. 17 patients were collected with relapses, despite maintenance treatment with oral azathioprine associated or not with oral prednisone at low doses (between 5 and 7.5 ml/day) or refractory relapses to previous intratympanic corticoid treatment being 19 affected ears...
Paper Details
Title
Intratympanic infliximab is a safe and effective rescue therapy for refractory immune-mediated hearing loss
Published Date
Nov 5, 2019
Volume
277
Issue
2
Pages
393 - 400
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History